Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v19.i1.20
pages 47-60

Cancer Treatment-Related Bone Disease

Sue A. Brown
Department of Medicine, University of Virginia, Charlottesville, Virginia, USA
Theresa A. Guise
Division of Endocrinology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900

ABSTRAKT

Bone health may be impaired in many patients being treated for cancer. Primary tumors that reside in or form metastases to bone can result in compromised skeletal integrity. It has also been increasingly recognized that patients undergoing therapies for treatment of cancer are at higher risk of bone loss. These include androgen-deprivation therapy for prostate cancer and aromatase inhibitor therapy for breast cancer, among others. Hypogonadism induced by many of these cancer treatments results in bone loss and increases the risk of osteoporosis and fractures. Progress has been made in identifying the role of oral and intravenous bisphosphonates to prevent bone loss in these patients. This review discusses bone loss associated with cancer treatments, with a focus on breast cancer, prostate cancer, and survivors of childhood malignancies.


Articles with similar content:

New Prospectives of Prostate Cancer Gene Therapy: Molecular Targets and Animal Models
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Chia-Ling Hsieh, Leland W. K. Chung
Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 1
Evan T. Keller
FLT3 Signaling and the Development of Inhibitors That Target FLT3 Kinase Activity
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 2
Wallace Y. Langdon
Precise Diagnosis and Treatment of Thymic Epithelial Tumors Based on Molecular Biomarkers
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 5-6
Jun Du, Xiao-Jun Zhou
The Cellular and Clinical Parameters of Anabolic Therapy for Osteoporosis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.13, 2003, issue 1
Clifford J. Rosen